New study aims to stop Alzheimer’s before it starts

After the National Alzheimer’s Plan was released, a major new drug trial to prevent Alzheimer’s disease was announced. In the study, 300 family members in Colombia who have a gene that guarantees that they will get Alzheimer’s, but who don’t yet have symptoms, will participate in a trial of an experimental drug called Crenezumab. Researchers hope the drug will attack the amyloid protein in the brain, considered a root cause of Alzheimer’s by many scientists, and keep the participants from experiencing dementia.
Read the article >>